Nuveen
BCYC icon

Nuveen’s Bicycle Therapeutics BCYC Stock Holding History

Nuveen’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.62K Buy
+1,541
New +$6.23K ﹤0.01% 4657

Other funds holding BCYC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Woodstock Corp
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.71B AUM 23.29% 1-Year Est. Return

Nuveen's BCYC Position: Q3 2026 in Review

Nuveen opened a new position in Bicycle Therapeutics (BCYC) in Q3 2026: 1,541 shares worth $5.62K. The stake represents ﹤0.01% of the portfolio and ranks #4657 among its holdings.

28 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Nuveen held 1,541 shares of Bicycle Therapeutics worth $5.62K as of Q3 2026.
  • Bicycle Therapeutics was a new Nuveen position in Q3 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4657 holding.
  • 28 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.